{
    "title": "Gilead asks FDA to take back lucrative orphan drug status on possible coronavirus treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8153631/Gilead-asks-FDA-lucrative-orphan-drug-status-possible-coronavirus-treatment.html",
    "date": "2020-03-25",
    "keywords": [
        "drug",
        "designation",
        "status",
        "fda",
        "wednesday",
        "development",
        "company",
        "gilead",
        "michael",
        "coronavirus",
        "treatment",
        "remdesivir",
        "covid19",
        "health",
        "step",
        "food",
        "administration",
        "agency",
        "biotech",
        "withdrawal",
        "illness",
        "monday",
        "advantage",
        "crisis",
        "ebola",
        "president",
        "trump",
        "virus",
        "orphan",
        "marketing",
        "exclusivity",
        "period",
        "disease",
        "profit",
        "patient",
        "withdrawn",
        "sponsor",
        "bernie",
        "approval",
        "timeline",
        "review",
        "advocacy",
        "group",
        "citizen",
        "population",
        "battle",
        "pandemic",
        "hydroxychloroquine",
        "incs",
        "reporting",
        "bengaluru",
        "erman",
        "maplewood",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}